MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 86,220 shares at $27.13 ($2.3M) on 2021-10-13, disclosed to the SEC on 2021-10-14.
Open-market sale of $2.3M ITOS by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.09 | 8,521 | $231K | 9.9% |
| 2 | $27.09 | 8,521 | $231K | 9.9% |
| 3 | $27.13 | 20,929 | $568K | 24.2% |
| 4 | $27.13 | 20,929 | $568K | 24.2% |
| 5 | $27.30 | 27,320 | $746K | 31.8% |
| Total | $27.18 avg | 86,220 |
| $2.3M |
| 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $12.5M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-09-30 | $581K | — | Filing → |